Dr. Heather Sue Gladue, DO

Dr. Gladue practices at Novant Health Midtown Outpatient Surgery in Charlotte, North Carolina.

Dr. Gladue's NPI, 1790949642, was assigned on July 10, 2008. Dr. Gladue graduated from Dr. Kiran C. Patel College of Osteopathic Medicine in 2008. Dr. Gladue holds North Carolina license 2015-01003.

Dr. Gladue's primary practice is Novant Health Midtown Outpatient Surgery, at 1918 Randolph Rd, Charlotte, NC 28207 in Mecklenburg County. The practice phone is (336) 277-8757.

Dr. Gladue's primary practice is Novant Health Midtown Outpatient Surgery in Charlotte, North Carolina. Dr. Gladue is also affiliated with Atrium Health Carolinas Medical Center. The medical group on file is Arthritis & Osteoporosis Consultants of the Carolinas (AOCC). Dmand AI also links Dr. Gladue to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Gladue practices, 2 sites in all. Vendor and product names are available with a free account.

Rheumatology is Dr. Gladue's primary specialty in the NPI Registry, under taxonomy code 207RR0500X. Dr. Gladue is board certified in internal medicine by the American Board of Internal Medicine. Dr. Gladue is licensed in North Carolina.

Dmand AI lists arteritis, arthritis, fibromyalgia and chronic pain, gout, joint pain, lupus, muscle pain, fibromyalgia, and limb pain and osteoporosis among the conditions Dr. Gladue treats.

CMS data shows 116,641 Medicare services from Dr. Gladue across 44 procedure codes in 2024, for 681 Medicare patients. Medicare paid $1,511,375 for them. Every service was in an office.

CMS counts 681 Medicare patients who saw Dr. Gladue in 2024. The largest group is 65 to 74, with 332 patients. 75% of them have arthritis, and 69% have high cholesterol. 4% are also on Medicaid. Their average risk score is 1.39, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Gladue's median patient age at 62, with 82% women.

In 2024, Dr. Gladue wrote 4,204 Medicare Part D claims for 546 patients. 87% of them were for generic drugs. CMS names the drug for 3,848 of them, across 61 drugs with 11 or more claims each, at $2,845,408 in total drug cost. In 2023, CMS named 3,479 claims across 56 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Dr. Gladue for performance year 2024, reported as part of a group. Dr. Gladue accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Gladue as offering telehealth.

Dmand AI links 16 papers to Dr. Gladue, published from 2013 to 2018. 2013 was the busiest year, with 6. The most frequent topics are Scleroderma, Systemic. Dr. Gladue has published most often in J Rheumatol. Dr. Gladue's most frequent co-authors are Dinesh Khanna, MD, Vallerie Victoria McLaughlin, MD and Nezam Ibrahim Altorok.

CMS Open Payments shows 1,504 general payments to Dr. Gladue from 45 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 68% of the total. AstraZeneca Pharmaceuticals LP paid the most, $57,222.

Dr. Gladue graduated from Dr. Kiran C. Patel College of Osteopathic Medicine in 2008. Dr. Gladue is a member of ACR.

Dr. Gladue is in network with 20 carriers, including Aetna, Excellus BlueCross BlueShield and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 13. Check the plan with the practice before a visit.